Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 3, 2010, Pages 792-801

  Réthelyi, János M ^a   Bakker, Steven C ^b   Polgár, Patrícia ^a   Czobor, Pál ^a,c   Strengman, Eric ^d   Pásztor, Péter I ^e   Kahn, René S ^b   Bitter, István ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ST JOHN'S HOSPITAL   (Hungary)

Author keywords

Deficit syndrome; DTNBP1; NRG1; Schizophrenia; Symptom severity

Indexed keywords

DYSBINDIN; ENZYME ACTIVATOR; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 5 PHOSPHATE 4 KINASE 2 ALPHA; PHOSPHATIDYLINOSITOL KINASE; PROTEIN G72; RGS4 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CARRIER PROTEINS; CASE-CONTROL STUDIES; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; HAPLOTYPES; HUMANS; HUNGARY; LINKAGE DISEQUILIBRIUM; MALE; NEUREGULIN-1; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RGS PROTEINS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 77949864266     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31049     Document Type: Article

References (65)

1. Allen NC, Bagade S,McQueen MB,Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 40:827-834.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Association Press.
3. Andreasen NC, Flaum M, Arndt S. 1992. The Comprehensive Assessment of Symptoms and History (CASH).Aninstrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49:615-623.
4. Bakker SC, Hoogendoorn ML, Selten JP, VerduijnW,Pearson PL, Sinke RJ, Kahn RS. 2004. Neuregulin 1: Genetic support for schizophrenia subtypes. Mol Psychiatry 9:1061-1063.
5. Bakker SC, Hoogendoorn ML, Hendriks J, Verzijlbergen K, Caron S, Verduijn W, Selten JP, Pearson PL, Kahn RS, Sinke RJ. 2007. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav 6:113-119.
6. Balázs J, Bitter I, Hideg K, Vitrai J. 1998. The Hungarian version of the M.I.N.I. and the M.I.N.I. Plus (in Hungarian). Psychiatr Hung 13: 160-168.
7. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
8. Burdick KE, Goldberg TE, Funke B, Bates JA, Lencz T, Kucherlapati R, Malhotra AK. 2007. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr Res 89:169-172.
9. Campbell DB, Ebert PJ, Skelly T, Stroup TS, Lieberman J, Levitt P, Sullivan PF. 2008a. Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia. Biol Psychiatry 63:32-41.
10. Campbell DB, Lange LA, Skelly T, Lieberman J, Levitt P, Sullivan PF. 2008b. Association of RGS2 and RGS5 variants with schizophrenia symptom severity. Schizophr Res 101:67-75.
11. Carpenter WT Jr, Heinrichs DW, Wagman AM. 1988. Deficit and nondeficit forms of schizophrenia: The concept. Am J Psychiatry 145: 578-583.
12. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T, Deshpande SN, Thelma BK, Ferrell RE, Middleton FA, et al. 2002. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 11:1373-1380.
13. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La Rosa P, et al. 2002. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 99:13675-13680.
14. Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates.
15. Corvin A, Donohoe G, McGhee K, Murphy K, Kenny N, Schwaiger S, Nangle JM, Morris D, Gill M. 2007. D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia. Neurosci Lett 426:97-100.
16. Corvin A, Donohoe G, Nangle JM, Schwaiger S, Morris D, Gill M. 2008. A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis. Neurosci Lett 431:146-149.
17. DeRosse P, Funke B, Burdick KE, Lencz T, Ekholm JM, Kane JM, Kucherlapati R, Malhotra AK. 2006. Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry 163:532-534.
18. DeRosse P, Lencz T, Burdick KE, Siris SG, Kane JM, Malhotra AK. 2008. The genetics of symptom-based phenotypes: Toward a molecular classification of schizophrenia. Schizophr Bull 34:1047-1053.
19. Detera-Wadleigh SD, McMahon FJ. 2006. G72/G30 in schizophrenia and bipolar disorder: Review and meta-analysis. Biol Psychiatry 60:106-114.
20. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87-98.
21. Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, Kane JM, Kucherlapati R, Malhotra AK. 2004. Association of theDTNBP1locus with schizophrenia in a U.S. population. Am J Hum Genet 75:891-898.
22. Gardner M, Gonzalez-Neira A, Lao O, Calafell F, Bertranpetit J, Comas D. 2006. Extreme population differences across neuregulin 1 gene, with implications for association studies. Mol Psychiatry 11:66-75.
23. Green EK, Raybould R, Macgregor S, Gordon-Smith K, Heron J, Hyde S, Grozeva D, Hamshere M, Williams N, Owen MJ, et al. 2005. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry 62:642-648.
24. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, Zhao Z. 2009. The dystrobrevin-binding protein 1 gene: Features and networks. Mol Psychiatry 14:18-29.
25. Harrison PJ, Law AJ. 2006. Neuregulin 1 and schizophrenia: Genetics, gene expression, and neurobiology. Biol Psychiatry 60:132-140.
26. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10:40-68.
27. He Z, Li Z, Shi Y, Tang W, Huang K, Ma G, Zhou J, Meng J, Li H, Feng G, et al. 2007. The PIP5K2A gene and schizophrenia in the Chinese population - A case-control study. Schizophr Res 94:359-365.
28. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276.
29. Kirkpatrick B, Galderisi S. 2008. Deficit schizophrenia: An update. World Psychiatry 7:143-147.
30. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, CarpenterWT Jr. 1989. The Schedule for the Deficit syndrome: An instrument for research in schizophrenia. Psychiatry Res 30:119-123.
31. Kirkpatrick B, Buchanan RW, Ross DE, CarpenterWTJr. 2001. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 58:165-171.
32. Li D, Collier DA, He L. 2006. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15:1995-2002.
33. Lin HF, Liu YL, Liu CM, Hung SI, Hwu HG, Chen WJ. 2005. Neuregulin 1 gene and variations in perceptual aberration of schizotypal personality in adolescents. Psychol Med 35:1589-1598.
34. Lindenmayer JP, Grochowski S, Hyman RB. 1995. Five factor model of schizophrenia: Replication across samples. Schizophr Res 14:229-234.
35. Mirnics K, Middleton FA, Stanwood GD,Lewis DA,Levitt P. 2001. Diseasespecific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6:293-301.
36. Munafo MR, Thiselton DL, Clark TG, Flint J. 2006. Association of the NRG1 gene and schizophrenia: A meta-analysis. Mol Psychiatry 11: 539-546.
37. Munafo MR, Attwood AS, Flint J. 2008. Neuregulin 1 genotype and schizophrenia. Schizophr Bull 34:9-12.
38. Mutsuddi M, Morris DW, Waggoner SG, Daly MJ, Scolnick EM, Sklar P. 2006. Analysis of high-resolution HapMap of DTNBP1 (dysbindin) suggests no consistency between reported common variant associations and schizophrenia. Am J Hum Genet 79:903-909.
39. Pae CU, Drago A, Kim JJ, Patkar AA, Jun TY, Lee C, Mandelli L, De Ronchi D, Paik IH, Serretti A. 2008. DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients. Neurosci Lett 440: 150-154.
40. Petryshen TL, Middleton FA, Kirby A, Aldinger KA, Purcell S, Tahl AR, Morley CP, McGann L, Gentile KL, Rockwell GN, et al. 2005. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 10:366-374, 328.
41. Ross DE, Kirkpatrick B, Karkowski LM, Straub RE, MacLean CJ, O'Neill FA, Compton AD, Murphy B, Walsh D, Kendler KS. 2000. Sibling correlation of deficit syndrome in the Irish study of high-density schizophrenia families. Am J Psychiatry 157:1071-1076.
42. Saggers-Gray L, Heriani H, Handoko HY, Irmansyah I, Kusumawardhani AA, Widyawati I, Amir N, Nasrun MW, Schwab SG, Wildenauer DB. 2008. Association of PIP5K2A with schizophrenia: A study in an Indonesian family sample. Am J Med Genet Part B 147B:1310-1313.
43. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, Burrell GJ, Rice JP, Nertney DA, Olincy A, et al. 2008. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: Implications for psychiatric genetics. Am J Psychiatry 165: 497-506.
44. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, Rietschel M, Trixler M, Maier W, et al. 2003. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 72:185-190.
45. Schwab SG, Knapp M, Sklar P, Eckstein GN, Sewekow C, Borrmann-Hassenbach M, Albus M, Becker T, Hallmayer JF, Lerer B, et al. 2006. Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. Mol Psychiatry 11:837-846.
46. Selvin S. 2004. Statistical analysis of epidemiologic data. New York: Oxford University Press.
47. Stefanis NC, Trikalinos TA, Avramopoulos D, Smyrnis N, Evdokimidis I, Ntzani EE, Ioannidis JP, Stefanis CN. 2007. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry 62:784-792.
48. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, et al. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877-892.
49. Stopkova P, Saito T, Fann CS, Papolos DF, Vevera J, Paclt I, Zukov I, Stryjer R, Strous RD, LachmanHM.2003. Polymorphism screening of PIP5K2A: Acandidate gene for chromosome 10p-linked psychiatric disorders.Am J Med Genet Part B 123B:50-58.
50. Stopkova P, Vevera J, Paclt I, Zukov I, Papolos DF, Saito T, Lachman HM. 2005. Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia. Psychiatr Genet 15:223-227.
51. Straub RE, Weinberger DR. 2006. Schizophrenia genes-Famine to feast. Biol Psychiatry 60:81-83.
52. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, et al. 2002. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71:337-348.
53. Strauss GP, Harrow M, Grossman LS, Rosen C. 2008. Periods of recovery in deficit syndrome schizophrenia: A 20-year multi-follow-up longitudinal study. Schizophr Bull. DOI: 10.1093/schbul/sbn167.
54. Sullivan PF. 2007. Spurious genetic associations. Biol Psychiatry 61: 1121-1126.
55. Sullivan PF, Kendler KS, Neale MC. 2003. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187-1192.
56. Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS, Wagner M, Lee S, Wright FA, Zou F, et al. 2008. Genomewide association for schizophrenia in the CATIE study: Results of stage 1. Mol Psychiatry 13:570-584.
57. Szekeres G, Keri S, Juhasz A, Rimanoczy A, Szendi I, Czimmer C, Janka Z. 2004. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet Part B 124B:1-5.
58. Talkowski ME, Seltman H, Bassett AS, Brzustowicz LM, Chen X, Chowdari KV, Collier DA, Cordeiro Q, Corvin AP, Deshpande SN, et al. 2006. Evaluation of a susceptibility gene for schizophrenia: Genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry 60:152-162.
59. Tek C, Kirkpatrick B, Buchanan RW. 2001. A five-year followup study of deficit and nondeficit schizophrenia. Schizophr Res 49:253-260.
60. The International HapMap Consortium. 2005. A haplotype map of the human genome. Nature 437:1299-1320.
61. Vrijenhoek T, Buizer-Voskamp JE, van der Stelt I, Strengman E, Sabatti C, Geurts van Kessel A, Brunner HG, Ophoff RA, Veltman JA. 2008. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am J Hum Genet 83:504-510.
62. Williams NM, O'Donovan MC, Owen MJ. 2005. Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? Schizophr Bull 31:800-805.
63. Wonodi I, Mitchell BD, Stine OC, Hong LE, Elliott A, Kirkpatrick B, Carpenter WT Jr, Thaker GK, Buchanan RW. 2006. Lack of association between COMT gene and deficit/nondeficit schizophrenia. Behav Brain Funct 2:42.
64. Yue W, Kang G, Zhang Y, Qu M, Tang F, Han Y, Ruan Y, Lu T, Zhang J, Zhang D. 2007. Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects. Neurosci Lett 416: 96-100.
65. Zhang F, St Clair D, Liu X, Sun X, Sham PC, Crombie C, Ma X, Wang Q, Meng H, Deng W, et al. 2005. Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia. Genes Brain Behav 4:444-448.